Significados de patient subgroup en inglés

This patient subgroup should ideally be evaluated in future randomized controlled trials.

The study was focused on a hospitalized patient subgroup with cardiac comorbidities.

This therapeutic strategy holds promise for this AML patient subgroup in future clinical studies.

However, neither tropisetron nor ondansetron was significantly different from the placebo in this patient subgroup.

Further identification of this patient subgroup is crucial to optimize therapy for older patients with OPSCC.

Further studies should concentrate on that patient subgroup.

However, an evaluation of factors that may affect prognosis in this patient subgroup has not been undertaken.

Therefore, COMACHI was conducted to confirm the efficacy and safety of this treatment regimen in this patient subgroup.

Conclusions: No clinically significant bleeding events were recorded with coadministration of sitaxentan and acenocoumarol in this patient subgroup.

Only 15% of the 26- patient subgroup had an abnormal octreotide scintigraphy result.

There is thus an urgent need for randomized trials to define the effectiveness of MT in this patient subgroup.

Conclusions: Rib fixation for flail chest improves short-term outcome, although the indication and patient subgroup who would benefit most remain unclear.

Further studies with chemoradiation are warranted in patients with positive resection margins, as chemotherapy appeared relatively ineffective in this patient subgroup.

Furthermore, it should help in selecting a patient subgroup with small bowel obstruction due to adhesions, which might be treated conservatively.

The present work investigated whether the positive signal on clinical outcome in this patient subgroup was mirrored by respective poststroke biomarker profiles.

However, in daily practice it is often more important to know how a model performs in a patient subgroup at a specific ICU.